Denali Advisors’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$798K Sell
3,265
-17
-0.5% -$3.96K 0.09% 207
2025
Q4
$679K Buy
3,282
+49
+2% +$9.69K 0.08% 222
2025
Q3
$600K Sell
3,233
-1,811
-36% -$310K 0.07% 216
2025
Q2
$771K Sell
5,044
-52
-1% -$7.99K 0.08% 196
2025
Q1
$845K Sell
5,096
-32
-0.6% -$5.01K 0.1% 188
2024
Q4
$742K Buy
5,128
+67
+1% +$10.4K 0.08% 199
2024
Q3
$820K Buy
+5,061
New +$806K 0.09% 197
2018
Q3
Sell
-42,700
Closed -$5.18M 280
2018
Q2
$5.18M Buy
+42,700
New +$5.33M 0.78% 48

Other funds holding JNJ

Denali Advisors's JNJ Position: Q1 2026 in Review

Denali Advisors reduced its Johnson & Johnson (JNJ) stake by 0.52% in Q1 2026, selling an estimated $3.96K and leaving 3,265 shares worth $798K. The position accounts for 0.09% of the portfolio, ranked #207.

Denali Advisors first reported a position in JNJ in Q2 2018 and has held it in 8 quarters since. The position peaked at $5.18M in Q2 2018. 4,616 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.

  • Denali Advisors held 3,265 shares of Johnson & Johnson worth $798K as of Q1 2026.
  • Denali Advisors sold 17 Johnson & Johnson shares in Q1 2026, an estimated $3.96K.
  • Johnson & Johnson made up 0.09% of Denali Advisors's portfolio in Q1 2026, its #207 holding.
  • Denali Advisors first reported a position in Johnson & Johnson in Q2 2018 and has held it in 8 quarters since.
  • Denali Advisors's Johnson & Johnson position peaked at $5.18M in Q2 2018.
  • 4,616 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.

Based on Denali Advisors's 13F filing for Q1 2026, filed 8 May 2026.